A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems

Lisa M. Kaminskas(Monash University), Victoria M. McLeod(Monash University), Brian D. Kelly(Starpharma (Australia)), Gian Sberna(Starpharma (Australia)), Ben J. Boyd(Monash University), Mark Williamson, David J. Owen(Starpharma (Australia)), Christopher J. H. Porter(Monash University)
Nanomedicine Nanotechnology Biology and Medicine
June 13, 2011
Cited by 171

Abstract


Related Papers

No related papers found

Powered by citation graph analysis